INIS
assessments
6%
beams
5%
brachytherapy
8%
brain
11%
breasts
33%
cancer
100%
carcinomas
11%
clinical trials
5%
combined therapy
5%
comparative evaluations
17%
computed tomography
7%
computerized tomography
10%
data
20%
diseases
13%
doses
25%
esophagus
5%
evaluation
5%
guidelines
9%
images
11%
implementation
6%
information
5%
irradiation
17%
learning
13%
levels
5%
lung cells
22%
lungs
14%
lymph nodes
5%
machine learning
5%
management
7%
metastases
11%
netherlands
8%
optimization
5%
organs
6%
patients
86%
performance
7%
phantoms
6%
planning
13%
positron computed tomography
5%
prediction
12%
prostate
10%
protons
13%
quality assurance
5%
quality of life
6%
radiations
20%
radiotherapy
74%
range
5%
recommendations
5%
rectum
7%
reviews
13%
risks
23%
simulation
5%
surgery
12%
therapy
19%
tissues
8%
toxicity
11%
tumors
25%
validation
9%
volume
16%
Medicine and Dentistry
Arm
5%
Brachytherapy
6%
Breast Cancer
21%
Chemoradiotherapy
7%
Clinical Trial
5%
Computer Assisted Tomography
5%
Disease
10%
Dosimetry
6%
Head and Neck Cancer
7%
Immunotherapy
5%
Lung Cancer
9%
Malignant Neoplasm
8%
Mastectomy
5%
Neoplasm
15%
Non Small Cell Lung Cancer
18%
Overall Survival
6%
Prostate Cancer
6%
Proton Therapy
8%
Quality of Life
9%
Radiation Therapy
63%
Recurrence Risk
5%
Recurrent Disease
9%
Systematic Review
6%
Systemic Therapy
6%
Treatment Planning
8%
Uterine Cancer
5%
Keyphrases
Breast Cancer
12%
Colorectal Cancer
5%
Deep Learning
5%
Dutch
6%
Endometrial Cancer
5%
European Society
5%
Head-and-neck Cancer
8%
Lung Cancer
5%
Mastectomy
5%
Netherlands
9%
Non-small Cell Lung Cancer (NSCLC)
7%
Overall Survival
5%
Proton Therapy
6%
Quality of Life
6%
Radiation Therapy
19%
Radiotherapy
32%
Stage III Non-small Cell Lung Cancer
6%
Treatment Planning
6%
Tumor
5%